Madagascar vs Timor-Leste: Prevalence rate of obesity in adults
Madagascar
4.5%
in 2024
Timor-Leste
3.6%
in 2024
Madagascar rank
195th
Timor-Leste rank
197th
Prevalence rate of obesity in adults over time
- Madagascar
- Timor-Leste
How they compare
Madagascar currently reports 4.5% against 3.6% in Timor-Leste, a difference of 0.9%.
That makes Madagascar's figure about 1.3 times Timor-Leste's.
Across all 45 years both countries report, Madagascar has been ahead every year.
Madagascar ranks 195th and Timor-Leste ranks 197th of 199 countries.
Madagascar has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Madagascar | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 0.5% | 0.2% | 0.3% | Madagascar |
| 1990s | 0.8% | 0.4% | 0.5% | Madagascar |
| 2000s | 1.5% | 0.7% | 0.8% | Madagascar |
| 2010s | 2.7% | 1.6% | 1.1% | Madagascar |
| 2020s | 4.0% | 3.1% | 1.0% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Madagascar or Timor-Leste?
- Madagascar, at 4.5% against 3.6% in Timor-Leste as of 2024.
- What is the difference in prevalence rate of obesity in adults between Madagascar and Timor-Leste?
- 0.9%, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Timor-Leste?
- 45 years are reported by both, from 1980 to 2024.
- How do Madagascar and Timor-Leste rank globally for prevalence rate of obesity in adults?
- Madagascar ranks 195th and Timor-Leste ranks 197th of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.